Page last updated: 2024-09-05

esketamine and Chemical Dependence

esketamine has been researched along with Chemical Dependence in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Andriola, I; Barlati, S; Bassetti, R; Chiappini, S; Clerici, M; d'Andrea, G; De Filippis, S; Dell'Osso, B; Di Nicola, M; Martinotti, G; Pettorruso, M; Sensi, S; Vita, A1
De Fazio, P; de Filippis, R1
Borissova, A; Curran, HV; Grabski, M; Marsh, B; Morgan, CJA1
Berk, M; Brietzke, E; Dodd, S; Gorwood, P; Ho, R; Iosifescu, DV; Kasper, S; Kratiuk, K; Lee, JG; Lee, Y; Lopez Jaramillo, C; Lui, LMW; Mansur, RB; McIntyre, RS; Murrough, JW; Nemeroff, CB; Papakostas, GI; Rosenblat, JD; Sanacora, G; Stahl, S; Subramaniapillai, M; Thase, M; Vieta, E; Young, AH; Zarate, CA1
Fonseca-Perezamador, A; García-Mendoza, AM; Kobayashi-Romero, LF; Lamas-Aguilar, RM; Pérez-Esparza, R1

Reviews

2 review(s) available for esketamine and Chemical Dependence

ArticleYear
Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review.
    Behavioural brain research, 2020, 08-17, Volume: 392

    Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Ketamine; Male; Mental Disorders; Mental Health; Middle Aged; Psychotropic Drugs; Substance-Related Disorders; Treatment Outcome

2020
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
    The American journal of psychiatry, 2021, 05-01, Volume: 178, Issue:5

    Topics: Antidepressive Agents; Delivery of Health Care; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dissociative Disorders; Excitatory Amino Acid Antagonists; Humans; Hypertension; Implementation Science; Ketamine; Lower Urinary Tract Symptoms; Monitoring, Physiologic; Patient Selection; Personnel Staffing and Scheduling; Psychoses, Substance-Induced; Substance-Related Disorders; Suicidal Ideation

2021

Other Studies

3 other study(ies) available for esketamine and Chemical Dependence

ArticleYear
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2023, Volume: 74

    Topics: Administration, Intranasal; Adult; Antidepressive Agents; Comorbidity; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug-Related Side Effects and Adverse Reactions; Humans; Ketamine; Retrospective Studies; Substance-Related Disorders

2023
Esketamine nasal spray in severe bipolar depression with borderline personality disorder and history of multiple substance abuse: A case report.
    Bipolar disorders, 2023, Volume: 25, Issue:6

    Topics: Bipolar Disorder; Borderline Personality Disorder; Humans; Nasal Sprays; Substance-Related Disorders

2023
Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.
    Acta psychiatrica Scandinavica, 2019, Volume: 140, Issue:2

    Topics: Administration, Intranasal; Anesthetics, Dissociative; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Receptors, N-Methyl-D-Aspartate; Risk Factors; Substance-Related Disorders; Suicidal Ideation; United States; United States Food and Drug Administration

2019